1. Boorjian, Stephen A, Alemozaffar, Mehrdad, Konety, Badrinath R, Parker, Nigel R, Dinney, Colin P N. 2020. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. In The Lancet. Oncology, 22, 107-117. doi:10.1016/S1470-2045(20)30540-4. https://pubmed.ncbi.nlm.nih.gov/33253641/
2. Moore, Alyssa, Linden, Jérôme, Jentsch, James D. 2021. Syn3 Gene Knockout Negatively Impacts Aspects of Reversal Learning Performance. In eNeuro, 8, . doi:10.1523/ENEURO.0251-21.2021. https://pubmed.ncbi.nlm.nih.gov/34413083/
3. Yuan, Li, Yang, Xiaohui, Ellis, Jessie L, Fisher, Nicole M, Makaroff, Christopher A. 2012. The Arabidopsis SYN3 cohesin protein is important for early meiotic events. In The Plant journal : for cell and molecular biology, 71, 147-60. doi:10.1111/j.1365-313X.2012.04979.x. https://pubmed.ncbi.nlm.nih.gov/22381039/
4. Shore, Neal D, Boorjian, Stephen A, Canter, Daniel J, Parker, Nigel R, Dinney, Colin P N. 2017. Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35, 3410-3416. doi:10.1200/JCO.2017.72.3064. https://pubmed.ncbi.nlm.nih.gov/28834453/
智鼠故事 
